Cargando…
Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
Netupitant/palonosetron (NEPA; Akynzeo(®)), available in oral and intravenous (IV) formulations, is a fixed-dose combination of the neurokinin 1 (NK1) receptor antagonist netupitant (or the prodrug, fosnetupitant, in the IV formulation) and the second-generation serotonin 3 (5-HT(3)) receptor antago...
Autor principal: | Shirley, Matt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463343/ https://www.ncbi.nlm.nih.gov/pubmed/34292534 http://dx.doi.org/10.1007/s40265-021-01558-2 |
Ejemplares similares
-
Correction to: Netupitant/Palonosetron: A Review in Chemotherapy-Induced Nausea and Vomiting
por: Shirley, Matt
Publicado: (2021) -
Management of chemotherapy-induced nausea and vomiting by risk profile: role of netupitant/palonosetron
por: Lorusso, Vito
Publicado: (2016) -
Management of acute and delayed chemotherapy-induced nausea and vomiting: role of netupitant–palonosetron combination
por: Janicki, Piotr K
Publicado: (2016) -
Relugolix: A Review in Advanced Prostate Cancer
por: Shirley, Matt
Publicado: (2023) -
Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease
por: Shirley, Matt
Publicado: (2019)